Greg Garfield, JD
Greg is an executive with extensive experience in running medical technology companies, including managing and leading people at all levels, as well as operational management and business strategy and planning. Originally an attorney at Pillsbury Winthrop, Greg began his medical technology career at Guidant Corporation where he held a number of executive-level legal and business development positions in different Guidant operating companies. Following Guidant‘s acquisition by Boston Scientific, Greg joined Acclarent, Inc. where he served initially as Vice President of Corporate Development, and then as Acclarent’s Chief Operating Officer through the acquisition and integration of Acclarent by Ethicon, Inc., a Johnson & Johnson company. Greg currently serves on the Boards of C2 Therapeutics, Sonitus Medical, Aerin Medical, Rodo Medical, Cogent Therapeutics, ReVent Medical, and Semler Scientific. Greg received his BS in Agricultural Business Management from California Polytechnic State University, San Luis Obispo and his J.D. from the University of the Pacific, McGeorge School of Law.